Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hilmar Doerge"'
Autor:
Alexander Emmert, Friedrich A. Schoendube, Hilmar Doerge, Ulrike Olgemoeller, Bernhard C. Danner, Michael Quintel, Wolfgang Koerber, Carl-P. Criée
Publikováno v:
Open Journal of Thoracic Surgery. :63-71
Background and purpose: Patients with severely impaired pulmonary function have an increased operative risk for major lung resection. The clinical benefits of pre- and perioperative, non-invasive pressure support ventilation (NIPSV) have up to now no
Autor:
C. Sellin, Hilmar Doerge, Heiner Post, Friedrich A. Schoendube, Samuel Sossalla, Marlon Coulibaly, Jan D. Schmitto, Aron F Popov
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 35:229-234
Background: Current concepts of acute pulmonary embolism suggest that right ventricular (RV) dilatation and failure are the consequence of pressureoverload-inducedRVhypoperfusionandischemia.Methods:Sixteenhuman-sizedhybridpigswereinstrumented forthem
Combined mitral valve and coronary artery surgery: ischemic versus non-ischemic mitral valve disease
Autor:
Bruno J. Messmer, Friedrich A. Schoendube, Jaime F. Vazquez-Jimenez, M Voss, Hilmar Doerge, R Seipelt
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 20:270-275
Objectives: Mitral valve combined with coronary artery surgery is associated with a higher hospital mortality than each operation in particular. Controversy exists regarding the predictive value of ischemic mitral valve disease (MVD) on outcome. Meth
Autor:
Hilmar Doerge, Friedrich A. Schoendube, Jaime F. Vazquez-Jimenez, Bruno J. Messmer, R Seipelt, M Voss
Publikováno v:
Revista Española de Cardiología. 54:1377-1384
Introduccion y objetivos Identificar los factores que afectan precoz y tardiamente en el resultado de esta cirugia combinada, considerada de alto riesgo. Pacientes y metodo Entre 1984 y 1997 fueron operados 264 pacientes (edad media 63 ± 7,3 anos) c
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 47:9-13
BACKGROUND Pulmonary embolectomy remains the only option for patients with fulminant pulmonary embolism and failure or contraindication of thrombolysis even today. Increasing prevalence of heparin-induced thrombocytopenia type II (HIT) adds a new sig
Autor:
Hilmar Doerge, M. Grossmann, Ingo Merkel, Joachim Landrath, Friedrich A. Schoendube, Wolfgang Juettner
Publikováno v:
ASAIO Journal. 52:35A
Autor:
Hilmar Doerge, C Ballat, Katja Steinke, H Alekuzei, Friedrich A. Schoendube, Jan D. Schmitto, O Marseille
Publikováno v:
ASAIO Journal. 49:168